Authors: WAALKES MV GORIS H DONTJE BHJ SCHWENDENER RA SCHERPHOF G NIJHOF W

Citation: Mv. Waalkes et al., TOXICITY OF LIPOSOMAL 3'-5'-O-DIPALMITOYL-5-FLUORO-2'-DEOXYURIDINE INMICE, Anti-cancer drug design, 13(4), 1998, pp. 291-305

Authors: STORM G STEERENBERG PA WAALKES MV CROMMELIN DJA

Citation: G. Storm et al., EFFECTS OF INTRAPERITONEAL ADMINISTRATION OF FREE AND LIPOSOME-ENTRAPPED DOXORUBICIN ON RAT PERITONEAL-EXUDATE CELL-POPULATIONS, Journal of drug targeting., 4(4), 1996, pp. 255

Authors: MORI A KENNEL SJ WAALKES MV SCHERPHOF GL HUANG L

Citation: A. Mori et al., CHARACTERIZATION OF ORGAN-SPECIFIC IMMUNOLIPOSOMES FOR DELIVERY OF 3',5'-O-DIPALMITOYL-5-FLUORO-2'-DEOXYURIDINE IN A MOUSE LUNG-METASTASIS MODEL, Cancer chemotherapy and pharmacology, 35(6), 1995, pp. 447-456

Authors: WAALKES MV VANGALEN M MORSELT H STERNBERG B SCHERPHOF GL

Citation: Mv. Waalkes et al., INVITRO STABILITY AND CYTOSTATIC ACTIVITY OF LIPOSOMAL FORMULATIONS OF 5-FLUORO-2'-DEOXYURIDINE AND ITS DIACYLATED DERIVATIVES, Biochimica et biophysica acta, 1148(1), 1993, pp. 161-172